Lucideon Plans to Expand Headquarters
Lucideon announced that it is investing £1.5 million to expand its headquarters to include pharmaceutical quality-control testing laboratories.
Lucideon, a global provider of materials-development technologies, testing, resource efficiency, and assurance, announced that it plans to invest £1.5 million ($2.4 million USD) to expand its headquarters in Stoke-on-Trent, England to include pharmaceutical quality-control testing laboratories.
The facilities include chemistry and microbiology laboratories for pharamcopeial testing (British Pharmacopoeia, European Pharmacopoeia, United States Pharmacopeia, and Japanese Pharacopoeia), quality control (batch release) testing, method development and validation, raw material analysis, stability storage and water testing, and microbiology determination testing including sterility, endotoxin, and bioburden.
Source: Lucideon
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
